Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22885164 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Primary Rituximab and Maintenance
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: rituximab

Study has passed its completion date and status has not been verified in more than two years.